Global microbiome diagnostic market is anticipated to grow at a CAGR of 11.4% during the forecast period (2024-2031). The market growth is driven by the growing adoption of advanced technologies such as 16S rRNA sequencing, shotgun metagenomics, and metatranscriptomics with increasing demand for the human microbiome. Additionally, introducing novel solutions by the market players in collaboration with academic researchers bolsters market growth. Furthermore, the increasing integration of machine learning and bioinformatics, and the increasing adoption of multi-omics data for microbiome functional activities, are contributing significantly towards the market growth.
The global microbiome diagnostic market is classified by product (reagents & kits, and instruments), by technology (16s rRNA sequencing, shotgun metagenomics, metatranscriptomics, and others), by end-users (hospitals, academic and research institutes and biotechnology, and pharmaceutical companies), and by geographies (North America, Europe, Asia-Pacific, and Rest of the World).
The major players in the global microbiome diagnostic market Bio-Rad Laboratories, Inc., Illumina, Inc., Merck KGaA, Takara Bio Inc., and Thermo Fisher Scientific Inc., among others. The market players are contributing significantly to the market growth, by the adoption of various business strategies, such as collaborations, mergers and acquisitions, product portfolio diversification, and more.
Browse the full report description of “Microbiome Diagnostic Market Size, Share & Trends Analysis Report by Product (Reagents & Kits, and Instruments), by Technology (16S rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics, and Other), and by End-Users (Hospitals, Academic and Research Institutes and Biotechnology, and Pharmaceutical Companies) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/microbiome-diagnostic-market
Recent Developments
- In October 2024, Genefitletics launched India's first microbiome-driven model to predict cardiovascular diseases based on gut and oral microbiome gene expression. VASCOMATH is a predictive human biology model that enables the prediction and early detection of chronic diseases and provides interventions that can eliminate molecules involved in disease or infection using nutrition as medicine so that diseases do not even develop.
- In December 2023, The Dark Intelligence Group, Inc., conducted a study about the latest developments in the microbiome market in Asia. It highlighted the (then) recently launched ORAHYG microbiome diagnostic product by Sushant Kumar Ventures Pvt. Ltd, (Genefitletics). It is the first at-home oral microbiome functional activity test available in Asia. The product can decode the root causes of, gingivitis, dental cavities, bad breath, and gum disease. Additionally, it is useful for the early detection development of, Type 2 diabetes, dementia, arthritis, cardiovascular disease, and cancer.
- In January 2023, Genetic Analysis AS (GA) entered a Tech Transfer Agreement with Microbiome Research Pvt. Ltd. (MRPL). MRPL will launch a test service portfolio based on the GA-map® Dysbiosis Test, under the partnership. The product will be the first CE-IVD-marked standardized gut microbiome test on the Indian market. It will also target clinical research customers and medical customers.
- In June 2022, Genetic Analysis and Servatus entered into a strategic collaboration agreement to develop new microbiome diagnostic and therapeutic solutions. The first stage agreement involves the establishment of a ‘GA-map® Flagship Lab’ fully operational for microbiome analysis in Servatus’ Queensland manufacturing facility. Additionally, the partnership will utilize HumGut, the human gut genome collection, and the GA biobank with data from global healthy and diseased populations.
- In February 2022, Genetic Analysis AS launched the microbiome test on a new technology platform GA-map® Dysbiosis Test kit commercially on the Luminex MAGPIX® system. The MAGPIX® instrument enables up to 50 plex using MagPlex® Microspheres.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/microbiome-diagnostic-market